Orf-I and Orf-II-encoded proteins in HTLV-1 infection and persistence

Viruses

Volumn 3, Issue 6, 2011, Pages 861-885

  Edwards, Dustin ^a   Fenizia, Claudio ^a   Gold, Heather ^a   de Castro Amarante, Maria Fernanda ^a   Buchmann, Cody ^a   Pise Masison, Cynthia A ^a   Franchini, Genoveffa ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

HTLV 1; Human T cell leukemia lymphoma virus type 1; ORF I; ORF II; P12; P13; P30; P8

Indexed keywords

ADENOSINE TRIPHOSPHATASE; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 2; INTERLEUKIN 2 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; PROTEIN P130; PROTEIN P30; PROTEIN P8; REACTIVE OXYGEN METABOLITE; REX PROTEIN; STAT5 PROTEIN; TAX PROTEIN; TRANSCRIPTION FACTOR NFAT;

ALTERNATIVE RNA SPLICING; APOPTOSIS; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL CYCLE REGULATION; CLONAL ANERGY; DNA REPAIR; ENZYME ACTIVATION; ENZYME REPRESSION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; NONHUMAN; OPEN READING FRAME; PERSISTENT VIRUS INFECTION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS TRANSMISSION;

ANIMALS; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; OPEN READING FRAMES; RNA SPLICING; VIRAL PROTEINS;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 79959662367     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v3060861     Document Type: Review

References (118)

1. Poiesz, B.J.; Ruscetti, F.W.; Gazdar, A.F.; Bunn, P.A.; Minna, J.D.; Gallo, R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. U. S. A. 1980, 77, 7415-7419.
2. Poiesz, B.J.; Ruscetti, F.W.; Mier, J.W.; Woods, A.M.; Gallo, R.C. T-cell lines established from human T-lymphocytic neoplasias by direct response to T-cell growth factor. Proc. Natl. Acad. Sci. U. S. A. 1980, 77, 6815-6819.
3. Gallo, R.C. The first human retrovirus. Sci. Am. 1986, 255, 88-98.
4. Gessain, A.; Barin, F.; Vernant, J.C.; Gout, O.; Maurs, L.; Calender, A.; de The, G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985, 2, 407-410.
5. Watanabe, T. HTLV-1-associated diseases. Int. J. Hematol. 1997, 66, 257-278.
6. Buggage, R.R. Ocular manifestations of human T-cell lymphotropic virus type 1 infection. Curr. Opin. Ophthalmol. 2003, 14, 420-425.
7. Jones, K.S.; Petrow-Sadowski, C.; Huang, Y.K.; Bertolette, D.C.; Ruscetti, F.W. Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells. Nat. Med. 2008, 14, 429-436.
8. Igakura, T.; Stinchcombe, J.C.; Goon, P.K.; Taylor, G.P.; Weber, J.N.; Griffiths, G.M.; Tanaka, Y.; Osame, M.; Bangham, C.R. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science 2003, 299, 1713-1716.
9. N.; Gold, H.; Andresen, V.; Schwartz, O.; Jones, K.; Ruscetti, F.; Lockett, S.; Gudla, P.; Venzon, D.; Franchini, G. Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission. Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 20738-20743.
10. Pais-Correia, A.M.; Sachse, M.; Guadagnini, S.; Robbiati, V.; Lasserre, R.; Gessain, A.; Gout, O.; Alcover, A.; Thoulouze, M.I. Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses. Nat. Med. 2009, 16, 83-89.
11. Edlich, R.F.; Hill, L.G.; Williams, F.M. Global epidemic of human T-cell lymphotrophic virus type-I (HTLV-I): an update. J. Long Term Eff. Med. Implants 2003, 13, 127-140.
12. Hinuma, Y.; Nagata, K.; Misoka, M.; Nakai, T.; Matsumoto, T.; Kiroshita, K.; Shirakwa, S.; Miyoshi, I. Adult T-cell leukemia: Antigen in ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. U. S. A. 1981, 78, 6476-6480.
13. Seiki, M.; Hattori, S.; Hirayama, Y.; Yoshida, M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc. Natl. Acad. Sci. U. S. A. 1983, 80, 3618-3622.
14. Osame, M.; Izumo, S.; Igata, A.; Matsumoto, M.; Matsumoto, T.; Sonoda, S.; Tara, M.; Shibata, Y. Blood transfusion and HTLV-I associated myelopathy. Lancet 1986, 2, 104-105.
15. Kondo, T.; Kono, H.; Nonaka, H.; Miyamoto, N.; Yoshida, R.; Bando, F.; Inoue, H.; Miyoshi, I.; Hinuma, Y.; Hanaoka, M. Risk of adult T-cell leukaemia/lymphoma in HTLV-I carriers. Lancet 1987, 2, 159.
16. Yamaguchi, K.; Watanabe, T. Human T lymphotropic virus type-I and adult T-cell leukemia in Japan. Int. J. Hematol. 2002, 76, 240-245.
17. Murphy, E.L.; Hanchard, B.; Figueroa, J.P.; Gibbs, W.N.; Lofters, W.S.; Campbell, M.; Goedert, J.J.; Blattner, W.A. Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int. J. Cancer 1989, 43, 250-253.
18. Kaplan, J.E.; Osame, M.; Kubota, H.; Igata, A.; Nishitani, H.; Maeda, Y.; Khabbaz, R.F.; Janssen, R.S. The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. J. Acquir. Immune Defic. Syndr. 1990, 3, 1096-1101.
19. Maloney, E.M.; Cleghorn, F.R.; Morgan, O.S.; Rodgers-Johnson, P.; Cranston, B.; Jack, N.; Blattner, W.A.; Bartholomew, C.; Manns, A. Incidence of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1998, 17, 167-170.
20. Berneman, Z.N.; Gartenhaus, R.B.; Reitz, M.S., Jr.; Blattner, W.A.; Manns, A.; Hanchard, B.; Ikehara, O.; Gallo, R.C.; Klotman, M.E. Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. Proc. Natl. Acad. Sci. U. S. A. 1992, 89, 3005-3009.
21. Koralnik, I.J.; Gessain, A.; Klotman, M.E.; Lo Monico, A.; Berneman, Z.N.; Franchini, G. Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I. Proc. Natl. Acad. Sci. U. S. A. 1992, 89, 8813-8817.
22. Ciminale, V.; Pavlakis, G.N.; Derse, D.; Cunningham, C.P.; Felber, B.K. Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: Novel mRNAs and proteins produced by HTLV type I. J. Virol. 1992, 66, 1737-1745.
23. Fukumoto, R.; Andresen, V.; Bialuk, I.; Cecchinato, V.; Walser, J.C.; Valeri, V.W.; Nauroth, J.M.; Gessain, A.; Nicot, C.; Franchini, G. In vivo genetic mutations define predominant functions of the human T-cell leukemia/lymphoma virus p12I protein. Blood 2009, 113, 3726-3734.
24. Gaudray, G.; Gachon, F.; Basbous, J.; Biard-Piechaczyk, M.; Devaux, C.; Mesnard, J.M. The complementary strand of the human T-cell leukemia virus type 1 RNA genome encodes a bZIP transcription factor that down-regulates viral transcription. J. Virol. 2002, 76, 12813-12822.
25. Kiyokawa, T.; Seiki, M.; Imagawa, K.; Shimizu, F.; Yoshida, M. Identification of a protein (p40x) encoded by a unique sequence pX of human T-cell leukemia virus type I. Gann 1984, 75, 747-751.
26. Kiyokawa, T.; Seiki, M.; Iwashita, S.; Imagawa, K.; Shimizu, F.; Yoshida, M. p27x-III and p21x-III, proteins encoded by the pX sequence of human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. U. S. A. 1985, 82, 8359-8363.
27. Matsuoka, M.; Green, P.L. The HBZ gene, a key player in HTLV-1 pathogenesis. Retrovirology 2009, 6, 71.
28. Matsuoka, M. HTLV-1 bZIP factor gene: Its roles in HTLV-1 pathogenesis. Mol. Aspect. Med. 2010, 31, 359-366.
29. Younis, I.; Green, P.L. The human T-cell leukemia virus Rex protein. Front. Biosci. 2005, 10, 431-445.
30. Chlichlia, K.; Khazaie, K. HTLV-1 Tax: Linking transformation, DNA damage and apoptotic T-cell death. Chem. Biol. Interact. 2010, 188, 359-365.
31. Derse, D.; Mikovits, J.; Ruscetti, F. X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro. Virology 1997, 237, 123-128.
32. Bartoe, J.T.; Albrecht, B.; Collins, N.D.; Robek, M.D.; Ratner, L.; Green, P.L.; Lairmore, M.D. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo. J. Virol. 2000, 74, 1094-1100.
33. Collins, N.D.; Newbound, G.C.; Albrecht, B.; Beard, J.L.; Ratner, L.; Lairmore, M.D. Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo. Blood 1998, 91, 4701-4707.
34. Silverman, L.R.; Phipps, A.J.; Montgomery, A.; Ratner, L.; Lairmore, M.D. Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: Evidence of in vivo reversion. J. Virol. 2004, 78, 3837-3845.
35. Valeri, V.W.; Hryniewicz, A.; Andresen, V.; Jones, K.; Fenizia, C.; Bialuk, I.; Chung, H.K.; Fukumoto, R.; Parks, R.W.; Ferrari. M.G.; et al. Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits. Blood 2010, 116, 3809-3817.
36. Franchini, G. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood 1995, 86, 3619-3639.
37. Franchini, G.; Mulloy, J.C.; Koralnik, I.J.; Lo Monico, A.; Sparkowski, J.J.; Andresson, T.; Goldstein, D.J.; Schlegel, R. The human T-cell leukemia/lymphotropic virus type I p12I protein cooperates with the E5 oncoprotein of bovine papillomavirus in cell transformation and binds the 16-kilodalton subunit of the vacuolar H+ ATPase. J. Virol. 1993, 67, 7701-7704.
38. Felber, B.K.; Derse, D.; Athanassopoulos, A.; Campbell, M.; Pavlakis, G.N. Cross-activation of the Rex proteins of HTLV-I and BLV and of the Rev protein of HIV-1 and nonreciprocal interactions with their RNA responsive elements. New Biol. 1989, 1, 318-328.
39. Koralnik, I.J.; Fullen, J.; Franchini, G. The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments. J. Virol. 1993, 67, 2360-2366.
40. Johnson, J.M.; Harrod, R.; Franchini, G. Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1). Int. J. Exp. Pathol. 2001, 82, 135-147.
41. Ding, W.; Albrecht, B.; Luo, R.; Zhang, W.; Stanley, J.R.; Newbound, G.C.; Lairmore, M.D. Endoplasmic reticulum and cis-Golgi localization of human T-lymphotropic virus type 1 p12(I): association with calreticulin and calnexin. J. Virol. 2001, 75, 7672-7682.
42. Koralnik, I.J.; Lemp, J.F., Jr.; Gallo, R.C.; Franchini, G. In vitro infection of human macrophages by human T-cell leukemia/lymphotropic virus type I (HTLV-I). AIDS Res. Hum. Retrovir. 1992, 8, 1845-1849.
43. Dekaban, G.A.; Peters, A.A.; Mulloy, J.C.; Johnson, J.M.; Trovato, R.; Rivadeneira, E.; Franchini, G. The HTLV-I orfI protein is recognized by serum antibodies from naturally infected humans and experimentally infected rabbits. Virology 2000, 274, 86-93.
44. Pique, C.; Dokhelar, M.C. In vivo production of Rof and Tof proteins of HTLV type 1: Evidence from cytotoxic T lymphocytes. AIDS Res. Hum. Retrovir. 2000, 16, 1783-1786.
45. Trovato, R.; Mulloy, J.C.; Johnson, J.M.; Takemoto, S.; de Oliveira, M.P.; Franchini, G. A lysine-to-arginine change found in natural alleles of the human T-cell lymphotropic/leukemia virus type 1 p12(I) protein greatly influences its stability. J. Virol. 1999, 73, 6460-6467.
46. Ding, W.; Albrecht, B.; Kelley, R.E.; Muthusamy, N.; Kim, S.J.; Altschuld, R.A.; Lairmore, M.D. Human T-cell lymphotropic virus type 1 p12(I) expression increases cytoplasmic calcium to enhance the activation of nuclear factor of activated T cells. J. Virol. 2002, 76, 10374-10382.
47. Albrecht, B.; D'Souza, C.D.; Ding, W.; Tridandapani, S.; Coggeshall, K.M.; Lairmore, M.D. Activation of nuclear factor of activated T cells by human T-lymphotropic virus type 1 accessory protein p12(I). J. Virol. 2002, 76, 3493-3501.
48. Kim, S.J.; Ding, W.; Albrecht, B.; Green, P.L.; Lairmore, M.D. A conserved calcineurin-binding motif in human T lymphotropic virus type 1 p12I functions to modulate nuclear factor of activated T cell activation. J. Biol. Chem. 2003, 278, 15550-15557.
49. Nair, A.; Michael, B.; Hiraragi, H.; Fernandez, S.; Feuer, G.; Boris-Lawrie, K.; Lairmore, M. Human T lymphotropic virus type 1 accessory protein p12I modulates calcium-mediated cellular gene expression and enhances p300 expression in T lymphocytes. AIDS Res. Hum. Retrovir. 2005, 21, 273-284.
50. Nair, A.M.; Michael, B.; Datta, A.; Fernandez, S.; Lairmore, M.D. Calcium-dependent enhancement of transcription of p300 by human T-lymphotropic type 1 p12I. Virology 2006, 353, 247-257.
51. Kim, S.J.; Nair, A.M.; Fernandez, S.; Mathes, L.; Lairmore, M.D. Enhancement of LFA-1-mediated T cell adhesion by human T lymphotropic virus type 1 p12I1. J. Immunol. 2006, 176, 5463-5470.
52. Fukumoto, R.; Dundr, M.; Nicot, C.; Adams, A.; Valeri, V.W.; Samelson, L.E.; Franchini, G. Inhibition of T-cell receptor signal transduction and viral expression by the linker for activation of T cells-interacting p12(I) protein of human T-cell leukemia/lymphoma virus type 1. J. Virol. 2007, 81, 9088-9099.
53. Bunn, P.A., Jr.; Schechter, G.P.; Jaffe, E.; Blayney, D.; Young, R.C.; Matthews, M.J.; Blattner, W.; Broder, S.; Robert-Guroff, M.; Gallo, R.C. Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. N. Engl. J. Med. 1983, 309, 257-264.
54. Clark, J.W.; Robert-Guroff, M.; Ikehara, O.; Henzan, E.; Blattner, W.A. Human T-cell leukemia-lymphoma virus type 1 and adult T-cell leukemia-lymphoma in Okinawa. Cancer Res. 1985, 45, 2849-2852.
55. Migone, T.S.; Lin, J.X.; Cereseto, A.; Mulloy, J.C.; O'Shea, J.J.; Franchini, G.; Leonard, W.J. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I. Science 1995, 269, 79-81.
56. Collins, N.D.; D'Souza, C.; Albrecht, B.; Robek, M.D.; Ratner, L.; Ding, W.; Green, P.L.; Lairmore, M.D. Proliferation response to interleukin-2 and Jak/Stat activation of T cells immortalized by human T-cell lymphotropic virus type 1 is independent of open reading frame I expression. J. Virol. 1999, 73, 9642-9649.
57. Mulloy, J.C.; Crownley, R.W.; Fullen, J.; Leonard, W.J.; Franchini, G. The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor beta and gammac chains and affects their expression on the cell surface. J. Virol. 1996, 70, 3599-3605.
58. Nicot, C.; Mulloy, J.C.; Ferrari M.G.; Johnson, J.M.; Fu, K.; Fukumoto, R.; Trovato, R.; Fullen, J.; Leonard, W.J.; Franchini, G. HTLV-1 p12(I) protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells. Blood 2001, 98, 823-829.
59. Jefferies, W.A.; Burgert, H.G. E3/19K from adenovirus 2 is an immunosubversive protein that binds to a structural motif regulating the intracellular transport of major histocompatibility complex class I proteins. J. Exp. Med. 1990, 172, 1653-1664.
60. Schust, D.J.; Tortorella, D.; Seebach, J.; Phan, C.; Ploegh, H.L. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J. Exp. Med. 1998, 188, 497-503.
61. Piguet, V.; Schwartz, O.; Le Gall, S.; Trono, D. The downregulation of CD4 and MHC-I by primate lentiviruses: a paradigm for the modulation of cell surface receptors. Immunol. Rev. 1999, 168, 51-63.
62. Le Gall, S.; Erdtmann, L.; Benichou, S.; Berlioz-Torrent, C.; Liu, L.; Benarous, R.; Heard, J.M.; Schwartz, O. Nef interacts with the mu subunit of clathrin adaptor complexes and reveals a cryptic sorting signal in MHC I molecules. Immunity 1998, 8, 483-495.
63. Kerkau, T.; Bacik, I.; Bennink, J.R.; Yewdell, J.W.; Hunig, T.; Schimpl, A.; Schubert, U. The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules. J. Exp. Med. 1997, 185, 1295-1305.
64. Banerjee, P.; Feuer, G.; Barker, E. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells. J. Virol. 2007, 81, 9707-9717.
65. Fukudome, K.; Furuse, M.; Fukuhara, N.; Orita, S.; Imai, T.; Takagi, S.; Nagira, M.; Hinuma, Y.; Yoshie, O. Strong induction of ICAM-1 in human T cells transformed by human T-cell-leukemia virus type 1 and depression of ICAM-1 or LFA-1 in adult T-cell-leukemia-derived cell lines. Int. J. Cancer 1992, 52, 418-427.
66. Goldstein, D.J.; Finbow, M.E.; Andresson, T.; McLean, P.; Smith, K.; Bubb, V.; Schlegel, R. Bovine papillomavirus E5 oncoprotein binds to the 16K component of vacuolar H(+)-ATPases. Nature 1991, 352, 347-349.
67. Schapiro, F.; Sparkowski, J.; Adduci, A.; Suprynowicz, F.; Schlegel, R.; Grinstein, S. Golgi alkalinization by the papillomavirus E5 oncoprotein. J. Cell Biol. 2000, 148, 305-315.
68. Balotta, C.; Lusso, P.; Crowley, R.; Gallo, R.C.; Franchini, G. Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages. J. Virol. 1993, 67, 4409-4414.
69. Koralnik, I.J.; Mulloy, J.C.; Andresson, T.; Fullen, J.; Franchini, G. Mapping of the intermolecular association of human T cell leukaemia/lymphotropic virus type I p12I and the vacuolar H+-ATPase 16 kDa subunit protein. J. Gen. Virol. 1995, 76, 1909-1916.
70. Finbow, M.E.; Pitts, J.D.; Goldstein, D.J.; Schlegel, R.; Findlay, J.B. The E5 oncoprotein target: A 16-kDa channel-forming protein with diverse functions. Mol. Carcinog. 1991, 4, 441-444.
71. Clague, M.J.; Urbe, S.; Aniento, F.; Gruenberg, J. Vacuolar ATPase activity is required for endosomal carrier vesicle formation. J. Biol. Chem. 1994, 269, 21-24.
72. Nelson, N. Energizing porters by proton-motive force J. Exp. Biol. 1994, 196, 7-13.
73. Prchla, E.; Kuechler, E.; Blaas, D.; Fuchs, R. Uncoating of human rhinovirus serotype 2 from late endosomes. J. Virol. 1994, 68, 3713-3723.
74. Nawa, M. Japanese encephalitis virus infection in Vero cells: The involvement of intracellular acidic vesicles in the early phase of viral infection was observed with the treatment of a specific vacuolar type H+-ATPase inhibitor, bafilomycin A1. Microbiol. Immunol. 1997, 41, 537-543.
75. Taylor, J.M.; Brown, M.; Nejmeddine, M.; Kim, K.J.; Ratner, L.; Lairmore, M.; Nicot, C. Novel role for interleukin-2 receptor-Jak signaling in retrovirus transmission. J. Virol. 2009, 83, 11467-11476.
76. Yamamoto, N.; Okada, M.; Koyanagi, Y.; Kannagi, M.; Hinuma, Y. Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line. Science 1982, 217, 737-739.
77. Watkins, S.C.; Salter, R.D. Functional connectivity between immune cells mediated by tunneling nanotubules. Immunity 2005, 23, 309-318.
78. Sowinski, S.; Jolly, C.; Berninghausen, O.; Purbhoo, M.A.; Chauveau, A.; Kohler, K.; Oddos, S.; Eissmann, P.; Brodsky, F.M.; Hopkins, C.; et al. Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission. Nat. Cell Biol. 2008, 10, 211-219.
79. Ciminale, V.; D'Agostino, D.M.; Zotti, L.; Franchini, G.; Felber, B.K.; Chieco-Bianchi, L. Expression and characterization of proteins produced by mRNAs spliced into the X region of the human T-cell leukemia/lymphotropic virus type II. Virology 1995, 209, 445-456.
80. Ghorbel, S.; Sinha-Datta, U.; Dundr, M.; Brown, M.; Franchini, G.; Nicot, C. Human T-cell leukemia virus type I p30 nuclear/nucleolar retention is mediated through interactions with RNA and a constituent of the 60 S ribosomal subunit. J. Biol. Chem. 2006, 281, 37150-37158.
81. Baydoun, H.H.; Bellon, M.; Nicot, C. HTLV-1 Yin and Yang: Rex and p30 master regulators of viral mRNA trafficking. AIDS Rev. 2008, 10, 195-204.
82. Michael, B.; Nair, A.M.; Datta, A.; Hiraragi, H.; Ratner, L.; Lairmore, M.D. Histone acetyltransferase (HAT) activity of p300 modulates human T lymphotropic virus type 1 p30II-mediated repression of LTR transcriptional activity. Virology 2006, 354, 225-239.
83. Younis, I.; Khair, L.; Dundr, M.; Lairmore, M.D.; Franchini, G.; Green, P.L. Repression of human T-cell leukemia virus type 1 and type 2 replication by a viral mRNA-encoded posttranscriptional regulator. J. Virol. 2004, 78, 11077-11083.
84. Yamamoto, B.; Li, M.; Kesic, M.; Younis, I.; Lairmore, M.D.; Green, P.L. Human T-cell leukemia virus type 2 post-transcriptional control protein p28 is required for viral infectivity and persistence in vivo. Retrovirology 2008, 5, 38.
85. H, H.B.; Pancewicz, J.; Nicot, C. Human T-cell leukemia virus p30 inhibits homologous recombination and favors unfaithful DNA repair. Blood 2011, doi:10.1182/blood-2010-08-304600.
86. Choudhary, G.; Ratner, L. The HTLV-1 hbz antisense gene indirectly promotes tax expression via down-regulation of p30(II) mRNA. Virology 2010, 410, 307-315.
87. Boisvert, F.M.; van Koningsbruggen, S.; Navascues, J.; Lamond, A.I. The multifunctional nucleolus. Nat. Rev. Mol. Cell Biol. 2007, 8, 574-585.
88. Nicot, C.; Dundr, M.; Johnson, J.M.; Fullen, J.R.; Alonzo, N.; Fukumoto, R.; Princler, G.L.; Derse, D.; Misteli, T.; Franchini, G. HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nat. Med. 2004, 10, 197-201.
89. Sinha-Datta, U.; Datta, A.; Ghorbel, S.; Dodon, M.D.; Nicot, C. Human T-cell lymphotrophic virus type I rex and p30 interactions govern the switch between virus latency and replication. J. Biol. Chem. 2007, 282, 14608-14615.
90. Princler, G.L.; Julias, J.G.; Hughes, S.H.; Derse, D. Roles of viral and cellular proteins in the expression of alternatively spliced HTLV-1 pX mRNAs. Virology 2003, 317, 136-145.
91. D'Agostino, D.M.; Ciminale, V.; Zotti, L.; Chieco-Bianchi, L. Influence of Rex and intronic sequences on expression of spliced mRNAs produced by human T cell leukemia virus type I. AIDS Res. Hum. Retrovir. 1999, 15, 1351-1363.
92. Bai, X.T.; Baydoun, H.H.; Nicot, C. HTLV-I p30: A versatile protein modulating virus replication and pathogenesis. Mol. Aspect. Med. 2010, 31, 344-349.
93. Zhang, W.; Nisbet, J.W.; Bartoe, J.T.; Ding, W.; Lairmore, M.D. Human T-lymphotropic virus type 1 p30(II) functions as a transcription factor and differentially modulates CREB-responsive promoters. J. Virol. 2000, 74, 11270-11277.
94. Michael, B.; Nair, A.M.; Hiraragi, H.; Shen, L.; Feuer, G.; Boris-Lawrie, K.; Lairmore, M.D. Human T lymphotropic virus type-1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes. Retrovirology 2004, 1, 39.
95. Zhang, W.; Nisbet, J.W.; Albrecht, B.; Ding, W.; Kashanchi, F.; Bartoe, J.T.; Lairmore, M.D. Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by binding CREB binding protein/p300. J. Virol. 2001, 75, 9885-9895.
96. Zhang, J.L.; Sharma, P.L.; Crumpacker, C.S. Enhancement of the basal-level activity of HIV-1 long terminal repeat by HIV-1 nucleocapsid protein. Virology 2000, 268, 251-263.
97. Taylor, J.M.; Ghorbel, S.; Nicot, C. Genome wide analysis of human genes transcriptionally and post-transcriptionally regulated by the HTLV-I protein p30. BMC Genomics 2009, 10, 311.
98. Datta, A.; Sinha-Datta, U.; Dhillon, N.K.; Buch, S.; Nicot, C. The HTLV-I p30 interferes with TLR4 signaling and modulates the release of pro- and anti-inflammatory cytokines from human macrophages. J. Biol. Chem. 2006, 281, 23414-23424.
99. Datta, A.; Silverman, L.; Phipps, A.J.; Hiraragi, H.; Ratner, L.; Lairmore, M.D. Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival. Retrovirology 2007, 4, 49.
100. Anupam, R.; Datta, A.; Kesic, M.; Green-Church, K.; Shkriabai, N.; Kvaratskhelia, M.; Lairmore, M.D. Human T-lymphotropic virus type 1 p30 interacts with REG{gamma} and modulates ataxia telangiectasia mutated to promote cell survival. J. Biol. Chem. 2011, 286, 7661-7668.
101. Baydoun, H.H.; Pancewicz, J.; Bai, X.; Nicot, C. HTLV-I p30 inhibits multiple S phase entry checkpoints, decreases cyclin E-CDK2 interactions and delays cell cycle progression. Mol. Cancer 2010, 9, 302.
102. Makino, M.; Wakamatsu, S.; Shimokubo, S.; Arima, N.; Baba, M. Production of functionally deficient dendritic cells from HTLV-I-infected monocytes: implications for the dendritic cell defect in adult T cell leukemia. Virology 2000, 274, 140-148.
103. Robek, M.D.; Wong, F.H.; Ratner, L. Human T-cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes. J. Virol. 1998, 72, 4458-4462.
104. Chen, Y.M.; Chen, S.H.; Fu, C.Y.; Chen, J.Y.; Osame, M. Antibody reactivities to tumor-suppressor protein p53 and HTLV-I Tof, Rex and Tax in HTLV-I-infected people with differing clinical status. Int. J. Cancer 1997, 71, 196-202.
105. Arnold, J.; Yamamoto, B.; Li, M.; Phipps, A.J.; Younis, I.; Lairmore, M.D.; Green, P.L. Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense coded protein of HTLV-1. Blood 2006, 107, 3976-3982.
106. Berneman, Z.N.; Gartenhaus, R.B.; Reitz, M.S., Jr.; Klotman, M.E.; Gallo, R.C. cDNA sequencing confirms HTLV-I expression in adult T-cell leukemia/lymphoma and different sequence variations in vivo and in vitro. Leukemia 1992, 6, S67-S71.
107. D'Agostino, D.M.; Ranzato, L.; Arrigoni, G.; Cavallari, I.; Belleudi, F.; Torrisi, M.R.; Silic-Benussi, M.; Ferro, T.; Petronilli, V.; Marin, O. et al. Mitochondrial alterations induced by the p13II protein of human T-cell leukemia virus type 1. Critical role of arginine residues. J. Biol. Chem. 2002, 277, 34424-34433.
108. Ciminale, V.; Zotti, L.; D'Agostino, D.M.; Ferro, T.; Casareto, L.; Franchini, G.; Bernardi, P.; Chieco-Bianchi, L. Mitochondrial targeting of the p13II protein coded by the x-II ORF of human T-cell leukemia/lymphotropic virus type I (HTLV-I). Oncogene 1999, 18, 4505-4514.
109. Silic-Benussi, M.; Marin, O.; Biasiotto, R.; D'Agostino, D.M.; Ciminale, V. Effects of human T-cell leukemia virus type 1 (HTLV-1) p13 on mitochondrial K+ permeability: A new member of the viroporin family? FEBS Lett. 2010, 584, 2070-2075.
110. Silic-Benussi, M.; Cannizzaro, E.; Venerando, A.; Cavallari, I.; Petronilli, V.; La Rocca, N.; Marin, O.; Chieco-Bianchi, L.; Di Lisa, F.; D'Agostino, D.M. et al. Modulation of mitochondrial K(+) permeability and reactive oxygen species production by the p13 protein of human T-cell leukemia virus type 1. Biochim. Biophys. Acta 2009, 1787, 947-954.
111. Silic-Benussi, M.; Cavallari, I.; Vajente, N.; Vidali, S.; Chieco-Bianchi, L.; Di Lisa, F.; Saggioro, D.; D'Agostino, D.M.; Ciminale, V. Redox regulation of T-cell turnover by the p13 protein of human T-cell leukemia virus type 1: distinct effects in primary versus transformed cells. Blood 2010, 116, 54-62.
112. Silic-Benussi, M.; Cavallari, I.; Zorzan, T.; Rossi, E.; Hiraragi, H.; Rosato, A.; Horie, K.; Saggioro, D.; Lairmore, M.D.; Willems, L. et al. Suppression of tumor growth and cell proliferation by p13II, a mitochondrial protein of human T cell leukemia virus type 1. Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 6629-6634.
113. Biasiotto, R.; Aguiari, P.; Rizzuto, R.; Pinton, P.; D'Agostino, D.M.; Ciminale, V. The p13 protein of human T cell leukemia virus type 1 (HTLV-1) modulates mitochondrial membrane potential and calcium uptake. Biochim. Biophys. Acta 2010, 1797, 945-951.
114. Arnould, T.; Vankoningsloo, S.; Renard, P.; Houbion, A.; Ninane, N.; Demazy, C.; Remacle, J.; Raes, M. CREB activation induced by mitochondrial dysfunction is a new signaling pathway that impairs cell proliferation. EMBO J. 2002, 21, 53-63.
115. Hiraragi, H.; Michael, B.; Nair, A.; Silic-Benussi, M.; Ciminale, V.; Lairmore, M. Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13II sensitizes Jurkat T cells to Ras-mediated apoptosis. J. Virol. 2005, 79, 9449-9457.
116. Andresen, V.; Pise-Masison, C.; Sinha-Datta, U.; Valeri, V.W.; Parks, R.W.; Cecchinato, V.; Fukumoto, R.; Nicot, C.; Franchini, G. Suppression of HTLV-1 Replication by Tax-mediated 1 Re-routing of the p13 Viral Protein to Nuclear Speckles. Blood 2011, submitted for publication.
117. Pique, C.; Ureta-Vidal, A.; Gessain, A.; Chancerel, B.; Gout, O.; Tamouza, R.; Agis, F.; Dokhelar, M.C. Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides. J. Exp. Med. 2000, 191, 567-572.
118. Hiraragi, H.; Kim, S.J.; Phipps, A.J.; Silic-Benussi, M.; Ciminale, V.; Ratner, L.; Green, P.L.; Lairmore, M.D. Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo. J. Virol. 2006, 80, 3469-3476.